Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Global Industry Analysis and Forecast to 2020
Persistence Market Research
Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020
Persistence Market Research
1
Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Global Industry Analysis and Forecast to 2020
Persistence Market Research Released New Market Report on “Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020”.
Ataxia is a neurological condition, characterized by lack of voluntary coordination of muscle movement. Ataxia causes head trauma, stroke, Transient Ischemic Attack (TIA), tumor and toxic reaction. Progressive ataxia and weakness disorders are related to damage, degeneration or loss of neurons of the brain which leads to muscle coordination disability. The global market for treatments of syndromes of progressive ataxia and weakness disorders is categorized based on various drugs used for treatment of progressive ataxia syndromes, drugs for progressive weakness syndromes and by technology. The progressive ataxia syndrome segment is further sub-segmented into major diseases, such as Friedreich's ataxia, Gertsman-Straussler-Scheinker disease and Machado-Joseph disease. The progressive weakness syndrome segment includes amyotrophic lateral sclerosis, hereditary spastic paraplegia, hereditary neuropathies, progressive bulbar palsy and multiple sclerosis. The technology segment is further sub-segmented into small molecules based therapies and monoclonal antibody.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/syndromesprogressive-ataxia-weakness-disorders-market.asp
In terms of geography, the U.S. and Canada holds major market share of treatments for syndromes of progressive ataxia and weakness disorders market in North America. In Europe, Germany, France and...